Name

GemIri

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for GemIri

Name

Alternate Names

Gemcitabine Hydrochloride
Gemzar
LY 188011
LY-188011
LY188011 hydrochloride
Gemcitabine HCL

Abbreviations

None

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

613327

Primary Site

Bladder
Breast
non-small cell lung
ovarian
pancreatic cancer
Soft Tissue Sarcoma

Histology

None

Remarks

FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.

Coding

This drug should be coded

Name

Alternate Names

Camptosar
Camptosar Oral
Camptothecin-11
CPT 11
CPT-11
CPT11
U-101440E

Abbreviations

None

Category

Chemotherapy

Subcategory

Topoisomerase inhibitor

NSC Number

616348

Primary Site

Colorectal
head & neck
Non-small cell lung cancer (NSCLC)
pancreatic cancer
Small cell lung cancer (SCLC)

Histology

None

Remarks

Phase I (head & neck) Phase III SCLC pancreatic Topoisomerase I inhibitor. FDA approved use on colorectal cancer. Pharmacia.

Coding

This drug should be coded
Glossary